Target Audience
This conference has been designed for dermatologists, dermatology residents, oncologists, oncology fellows, primary care physicians, physicians involved in the care of patients with skin diseases, dermatology PAs, dermatology NPs, and students (medical, PA, NP).
Provider-ship:
This activity is jointly provided Medical Education Resources, Inc., a non-profit medical education company, and the Dermatology Research and Education Foundation.
Learning Objectives
At the conclusion of this course, you will be able to:
This activity is supported by an educational grant from Sun Pharma.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Dermatology Research and Education Foundation (DREF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional continuing Education (IPCE) credit for learning and change.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider-ship of Medical Education Resources (MER) and Skin Cancer Symposium®. MER is accredited by the ACCME to provide continuing medical education for physicians. MER designates this live activity for a maximum of 15 hours of AMA PRA Category 1 Credit(s)™.
PA Credit
PAs may receive a maximum of 15 hours of AMA PRA Category 1 Credit(s)™.
NP Credit
Medical Education Resources designates this live activity for a maximum of 15 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 15 contact hours.
Credit Designation
Attendees should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported conflicts of interest are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Hilary E. Baldwin, MD
Consulting Fees: Galderma, Ortho Dermatologics, EPI Health, Vyne, Almirall
Clay Cockerell, MD
Consulting Fees: Castle Biosciences
Brett Coldiron, MD
Nothing to disclose.
Daniel Eisen, MD
Nothing to disclose.
Steven Feldman, MD
Grants/Research Support: Lilly, AbbVie, Janssen, Pfizer, UCB, Almirall, Galderma
Consulting Fees: AbbVie, Janssen, Alvotech, vTv, BMS, Samsung, Pfizer, Boehringer, Dermavant, Aructis, Novartis, UCB, Helsinn, Sun, Almirall, LEO Pharma, Mylan, Forte, Arena, Biocon, Accordant, Argenx, Sanofi
Speakers' Bureaus: Lilly, AbbVie, Janssen, Alvotech, Amgen, Sun, Sanofi, Regeneron
Amit Garg, MD
Grants/Research Support: AbbVie, UCB, National Psoriasis Foundation
Consulting Fees: AbbVie, Aclaris, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB
Brett King, MD
Consulting Fees: AbbVie, AltruBio Inc., Almirall, AnaptysBio, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Meyers Squibb, Concert Pharmaceuticals, Horizon Therapeutics, Eli Lilly and Company
Speakers' Bureau: AbbVie, Incyte, LEO Pharma, Pfizer, Inc., Regeneron and Sanofi Genzyme
Leon Kircik, MD
See attached.
Robert Sidbury, MD
Grants/Research Support: Regeneron, Galderma, Pfizer, UCB
Consulting Fees: LEO Pharma, Pfizer
Speakers' Bureau: Beiersdorf
Eric Simpson, MD
Grants/Research Support: AbbVie, Amgen, Arcutis, Asian Corevita, Dermira, Eli Lilly, Incyte, Kyowa Hakko Kirin, LEO Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi, Target Derm
Consulting Fees: AbbVie, Amgen, Arena Pharmaceuticals, Asian Pharma, Boston Consulting Group, Collective Acumen, LLC, Dermira, Eli Lilly, Evidera, ExcerptMedica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin Pharmaceutical Development, LEO Pharma, Medscape LLC, Pfizer, Physicians World LLC, Regeneron, Sanofi-Genzyme, Trevi Therapeutics, WebMD
Linda Stein Gold, MD
Grants/Research Support: Pfizer, AbbVie, Amgen, Novartis, Galderma, Lilly, Dermavant, Arcutis, Incyte, Dermata
Consulting Fees: Pfizer, AbbVie, Amgen, Novartis, Galderma, Lilly, Dermavant, Arcutis, Incyte, Dermira, BMS, UCB, Janssen, Sanofi, Regeneron, EPI
Speakers' Bureau: Pfizer, AbbVie, Galderma, Incyte, Sanofi, Regeneron, Sun, EPI
Hensin Tsao, MD, PhD
Nothing to disclose.
Mavis Walker
Nothing to disclose.
Steven Wang, MD
Nothing to disclose.
Oliver Wisco, DO
Nothing to disclose.
Jashin Wu, MD
Grants/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer
Consulting Fees: AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Bausch Health, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, DermTech, Dr. Reddy's Laboratories, Eli Lilly, EPI Health, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Samsung Bioepis, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, and Zerigo Health
Speakers' Bureau: AbbVie, Amgen, Bausch Health, Novartis, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, UCB
The planners at Medical Education Resources and Compass Management and Consulting have no financial relationships to disclose.
Evaluation & Certificate:
Statements of credit/participation will be awarded based on the participant’s attendance at each session, participation in the pre/post-test and submission of the activity evaluation form. Participants will be sent an email at the conclusion of the meeting to claim credit. If you have questions about this CME/CE activity, please contact Medical Education Resources at 303-798-9682 or sjones@cmepartner.org. Credit must be claimed by July 12, 2022.
This conference has been designed for dermatologists, dermatology residents, oncologists, oncology fellows, primary care physicians, physicians involved in the care of patients with skin diseases, dermatology PAs, dermatology NPs, and students (medical, PA, NP).
Provider-ship:
This activity is jointly provided Medical Education Resources, Inc., a non-profit medical education company, and the Dermatology Research and Education Foundation.
Learning Objectives
At the conclusion of this course, you will be able to:
- Discern various options for managing skin cancer and actinic keratosis
- Discuss the medical and surgical treatments for basal cell carcinoma.
- Discuss the medical and surgical treatments for squamous cell carcinoma.
- Discuss histopathology of melanoma and other skin cancers.
- Discern different lesions with dermoscopy.
- Evaluate older and newer therapies in atopic dermatitis.
- Assess the various therapies available for acne.
- Discuss the new treatments for psoriasis and how to choose between them.
- Describe the concepts learned that can be incorporated directly into clinical practice.
This activity is supported by an educational grant from Sun Pharma.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Dermatology Research and Education Foundation (DREF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional continuing Education (IPCE) credit for learning and change.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider-ship of Medical Education Resources (MER) and Skin Cancer Symposium®. MER is accredited by the ACCME to provide continuing medical education for physicians. MER designates this live activity for a maximum of 15 hours of AMA PRA Category 1 Credit(s)™.
PA Credit
PAs may receive a maximum of 15 hours of AMA PRA Category 1 Credit(s)™.
NP Credit
Medical Education Resources designates this live activity for a maximum of 15 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 15 contact hours.
Credit Designation
Attendees should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported conflicts of interest are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Hilary E. Baldwin, MD
Consulting Fees: Galderma, Ortho Dermatologics, EPI Health, Vyne, Almirall
Clay Cockerell, MD
Consulting Fees: Castle Biosciences
Brett Coldiron, MD
Nothing to disclose.
Daniel Eisen, MD
Nothing to disclose.
Steven Feldman, MD
Grants/Research Support: Lilly, AbbVie, Janssen, Pfizer, UCB, Almirall, Galderma
Consulting Fees: AbbVie, Janssen, Alvotech, vTv, BMS, Samsung, Pfizer, Boehringer, Dermavant, Aructis, Novartis, UCB, Helsinn, Sun, Almirall, LEO Pharma, Mylan, Forte, Arena, Biocon, Accordant, Argenx, Sanofi
Speakers' Bureaus: Lilly, AbbVie, Janssen, Alvotech, Amgen, Sun, Sanofi, Regeneron
Amit Garg, MD
Grants/Research Support: AbbVie, UCB, National Psoriasis Foundation
Consulting Fees: AbbVie, Aclaris, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB
Brett King, MD
Consulting Fees: AbbVie, AltruBio Inc., Almirall, AnaptysBio, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Meyers Squibb, Concert Pharmaceuticals, Horizon Therapeutics, Eli Lilly and Company
Speakers' Bureau: AbbVie, Incyte, LEO Pharma, Pfizer, Inc., Regeneron and Sanofi Genzyme
Leon Kircik, MD
See attached.
Robert Sidbury, MD
Grants/Research Support: Regeneron, Galderma, Pfizer, UCB
Consulting Fees: LEO Pharma, Pfizer
Speakers' Bureau: Beiersdorf
Eric Simpson, MD
Grants/Research Support: AbbVie, Amgen, Arcutis, Asian Corevita, Dermira, Eli Lilly, Incyte, Kyowa Hakko Kirin, LEO Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi, Target Derm
Consulting Fees: AbbVie, Amgen, Arena Pharmaceuticals, Asian Pharma, Boston Consulting Group, Collective Acumen, LLC, Dermira, Eli Lilly, Evidera, ExcerptMedica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin Pharmaceutical Development, LEO Pharma, Medscape LLC, Pfizer, Physicians World LLC, Regeneron, Sanofi-Genzyme, Trevi Therapeutics, WebMD
Linda Stein Gold, MD
Grants/Research Support: Pfizer, AbbVie, Amgen, Novartis, Galderma, Lilly, Dermavant, Arcutis, Incyte, Dermata
Consulting Fees: Pfizer, AbbVie, Amgen, Novartis, Galderma, Lilly, Dermavant, Arcutis, Incyte, Dermira, BMS, UCB, Janssen, Sanofi, Regeneron, EPI
Speakers' Bureau: Pfizer, AbbVie, Galderma, Incyte, Sanofi, Regeneron, Sun, EPI
Hensin Tsao, MD, PhD
Nothing to disclose.
Mavis Walker
Nothing to disclose.
Steven Wang, MD
Nothing to disclose.
Oliver Wisco, DO
Nothing to disclose.
Jashin Wu, MD
Grants/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer
Consulting Fees: AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Bausch Health, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, DermTech, Dr. Reddy's Laboratories, Eli Lilly, EPI Health, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Samsung Bioepis, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, and Zerigo Health
Speakers' Bureau: AbbVie, Amgen, Bausch Health, Novartis, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, UCB
The planners at Medical Education Resources and Compass Management and Consulting have no financial relationships to disclose.
Evaluation & Certificate:
Statements of credit/participation will be awarded based on the participant’s attendance at each session, participation in the pre/post-test and submission of the activity evaluation form. Participants will be sent an email at the conclusion of the meeting to claim credit. If you have questions about this CME/CE activity, please contact Medical Education Resources at 303-798-9682 or sjones@cmepartner.org. Credit must be claimed by July 12, 2022.
|
|
